home / stock / athjf / athjf message board
Subject | By | Source | When |
---|---|---|---|
next sarepta here is possible | BioSpecialist | investorshub | 08/08/2019 2:12:54 PM |
phase 2 results of the DMD trial in | BioSpecialist | investorshub | 08/08/2019 2:12:19 PM |
huge upside potential here | BioSpecialist | investorshub | 08/08/2019 2:11:49 PM |
hello | BioSpecialist | investorshub | 08/08/2019 2:11:20 PM |
Stock Tracker: Latest Antisense Therap Ltd (ATHJF) Headlines Antisense Therapeutics Selected to Pres | Stock_Tracker | investorshangout | 03/09/2014 4:21:45 AM |
chartguy89: ATHJF 0.15 Stock Charts $ATHJF 1 Month Chart | chartguy89 | investorshangout | 03/06/2014 5:00:43 AM |
Stock Tracker: ATHJF Recent News Antisense Therapeutics Selected to Present at Biotech Showcase(TM) | Stock_Tracker | investorshangout | 03/02/2014 11:36:06 PM |
chartguy89: ATHJF Stock Charts Sunday, February 23, 2014 at 1:29:28 AM $ATHJF Last: +0.004 | chartguy89 | investorshangout | 02/23/2014 6:29:41 AM |
News, Short Squeeze, Breakout and More Instantly...
Antisense Therapeutics Company Name:
ATHJF Stock Symbol:
OTCMKTS Market:
Antisense Therapeutics Website:
New York, NY, March 09, 2022 (GLOBE NEWSWIRE) -- Antisense Therapeutics Limited [ASX: ANP | US OTC: ATHJY | FSE: AWY] will deliver a virtual presentation on its antisense drug at the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference later this week. Dr. George ...
MELBOURNE, AUSTRALIA / ACCESSWIRE / May 23, 2018 / Antisense Therapeutics (the "Company" or "ANP") (ASX: ANP; OTC PINK: ATHJF) is pleased to announce the acceptance for publication of previously reported positive Phase II clinical trial data on ATL1103 (atesidorsen) in the leading peer-revie...
MELBOURNE, AUSTRALIA / ACCESSWIRE / February 28, 2018 / Antisense Therapeutics ("ANP" or the "Company") (ASX: ANP; OTC PINK: ATHJF) is pleased to advise that the Company has received approval from the Royal Children's Hospital (RCH), Melbourne Human Research Ethics Committee, to undertake a ...